Organization · Venture Capital
Presight Capital
Presight Capital is an international venture capital firm based in the United States, focusing on early-stage technology companies across various sectors. It is associated with Apeiron Investment Group and invests in ambitious founders globally.
Overview
What Presight Capital does
What Presight Capital is
Presight Capital is an international venture capital firm based in the United States, focusing on early-stage technology companies across various sectors. It is associated with Apeiron Investment Group and invests in ambitious founders globally.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- April 30, 2026
Official channels
Find Presight Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Presight Capital as a funder
Investment thesis
Presight Capital backs ambitious founders across sectors, stages, and geographies, with a strong bias toward transformative and sometimes non-consensus science and technology.
Focus narrative
Presight Capital invests in early-stage technology sectors, emphasizing innovation and growth potential. The firm is particularly interested in biotech, life sciences, deep tech, fintech, AI/ML, and other transformative technologies. Its investment strategy includes backing companies that are often complex and capital-intensive, with a focus on helping them expand into new markets.
Value beyond capital
Presight Capital adds value to its portfolio companies by leveraging its extensive network and regulatory knowledge to help startups navigate complex markets, particularly in the US and Europe. The firm is positioned to co-lead later-stage rounds when conviction is high, providing not just capital but also strategic guidance and support for growth.
Terms and economics
- Typical check
- $500,000–$100,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A · Growth Equity
- Regions
- North AmericaEuropeAsia
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded notable exits
- AbCellera and Compass Pathways
Portfolio context
Notable portfolio companies include: Peptilogics: A clinical-stage biotech developing therapeutics for medical device infections. AbCellera: An AI-powered drug discovery company that has gone public. Compass Pathways: A company focused on psychedelic therapeutics and psilocybin treatment. ATAI Life Sciences: A biotech company associated with psychedelic therapeutics. Blackrock Neurotech: A neurotechnology company specializing in brain-computer interfaces. SmithRx: A pharmacy benefit management replacement model. Duetti: A music financing and rights platform. AlaanPay: A fintech/payments company.
Common questions
What to know about Presight Capital
Upseed classifies Presight Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.